TATA INDIA PHARMA AND HEALTHCARE FUND REGULAR PLAN GROWTH

Thematic • Very High Risk

TATA INDIA PHARMA AND HEALTHCARE FUND REGULAR PLAN GROWTH

Category: Thematic

CRISIL Rating: Very High Risk

Code: TAIPHG-GR

NAV

₹30.09

0.24 (0.79%)
2026-02-25
Fund Rating

3 ⭐

Fund Information
Fund Size (AUM): 123.95 CR
Fund Strategy: Very High Risk
Expense Ratio: 2.1400%
Fund Manager:
Min Lump Sum: ₹5,000.00
Min SIP: ₹100.00
ISIN: INF277K016A9
Benchmark:
23.56% 3Y annualised
NAV

₹30.09

2026-02-25
Fund Rating

3 ⭐

Fund Size

123.95 CR

Fund Strategy

Very High Risk

₹500 ₹100,000
Total Investment: ₹15,000
Total Value: ₹0
Login to Invest

Login to create portfolios and start investing

Sector Allocation
Top Holdings
Security Name Weight (%)
Sun Pharmaceuticals Industries Ltd 11.17%
Cash / Net Current Asset 7.36%
Apollo Hospitals Enterprise Ltd 7.19%
Cipla Ltd 5.76%
Divi's Laboratories Ltd 5.58%
Aurobindo Pharma Ltd 5.44%
Fortis Healthcare Ltd 5.30%
Lupin Ltd 4.58%
Aster DM Healthcare Ltd Ordinary Shares 4.45%
Wockhardt Ltd 3.67%

Fund Rating

3 out of 5

Funds in Same Category

No other funds found in this category.